ENHANCEMENT IN GASTRIC-MUCOSAL EGF AND PDGF RECEPTOR EXPRESSION WITH ULCER HEALING BY SULGLYCOTIDE

Citation
J. Piotrowski et al., ENHANCEMENT IN GASTRIC-MUCOSAL EGF AND PDGF RECEPTOR EXPRESSION WITH ULCER HEALING BY SULGLYCOTIDE, General pharmacology, 26(4), 1995, pp. 749-753
Citations number
21
Categorie Soggetti
Pharmacology & Pharmacy
Journal title
ISSN journal
03063623
Volume
26
Issue
4
Year of publication
1995
Pages
749 - 753
Database
ISI
SICI code
0306-3623(1995)26:4<749:EIGEAP>2.0.ZU;2-3
Abstract
1. The effect of an antiulcer agent, sulglycotide, on mucosal expressi on of EGF and PDGF receptors with chronic ulcer healing was investigat ed. 2. Rats with experimentally-induced gastric ulcers were treated tw ice daily for 14 consecutive days, either with sulglycotide at 200 mg/ kg or vehicle, and at different stages of treatment used for quantitat ion of gastric mucosal EGF and PDGF receptors. 3. The ulcer healing wa s accompanied by an increase in mucosal expression of both types of re ceptors. A 1.8-fold increase in EGF and 3.1-fold increase in PDGF rece ptors occurred by the 4th day following the development of ulcer and r eached a maximum of 2.4-3.9-fold increase by the 10-14th day. 4. Treat ment with sulglycotide caused accelerated ulcer healing accompanied by a significant enhancement in the receptors expression. A 2.3- and 3.6 -fold increase in EGF and PDGF receptor expression occurred by the 4th day of sulglycotide treatment, reaching a 5.5- and 5.6-fold respectiv e increase by the 10th day when the ulcer essentially healed. 5. The r esults attest to the ability of sulglycotide to stimulate the gastric mucosal proliferative activities associated with ulcer healing.